CompanyGraph
Shenzhen Kangtai Biological Products Co., Ltd.
300601 · SZSE · China
biokangtai.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.03B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.59: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.29%Below 5Y avg (0.78%)
Annual Rate
CNY 0.04Paid annual
Payout Ratio
43.8%Sustainable
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.57BCNY2.03B · vs all stocks (USD)
Trailing P/E
151.88xRevenue (TTM)
2.55BCNY381.11M · vs all stocks (USD)
Profit Margin
3.26%Beta
0.6210xvs all stocks
52-Week Change
-28.32%vs all stocks
Market Capitalization
13.57BCNY2.03B · vs all stocks (USD)
Enterprise Value
12.81BCNY1.91B · vs all stocks (USD)
Trailing P/E
151.88xForward P/E
42.39xPrice to Sales (TTM)
5.31xPrice to Book (MRQ)
1.41xEnterprise to Revenue
5.02xEnterprise to EBITDA
25.97xGross Margin
71.55%Profit Margin
3.26%Operating Margin
3.28%Return on Assets (TTM)
0.39%Return on Equity (TTM)
0.83%Revenue (TTM)
2.55BCNY381.11M · vs all stocks (USD)
Revenue per Share (TTM)
2.43CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-14.10%Gross Profit (TTM)
1.77BCNY264.74M · vs all stocks (USD)
EBITDA (TTM)
327.22MCNY48.83M · vs all stocks (USD)
Net Income (TTM)
83.18MCNY12.41M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
12.90%Operating Cash Flow (TTM)
584.68MCNY87.25M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
38.94MCNY5.81M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0350CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
0.29%vs all stocks
5-Year Average Dividend Yield
0.78%vs all stocks
Payout Ratio
43.75%Minority Interest (Equity)
-155.09KCNYFY2025 · Dec 31, 2025Revenue
2.67BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
676.61MCNYFY2025 · Dec 31, 2025Gross Profit
2.00BCNYFY2025 · Dec 31, 2025Operating Income
251.37MCNY37.51M · vs all stocks (USD)
Pre-tax Income
45.46MCNYFY2025 · Dec 31, 2025Income Tax Expense
-24.81MCNYFY2025 · Dec 31, 2025Net Income
70.27MCNYFY2025 · Dec 31, 2025EBIT
164.50MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
736.72MCNYFY2025 · Dec 31, 2025Research & Development
543.42MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
931.81MCNYFY2025 · Dec 31, 2025Other Operating Expenses
39.89MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
77.97MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
119.03MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.17BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.17BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
70.27MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
56.52KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
332.54MCNYFY2025 · Dec 31, 2025Free Cash Flow
923.53KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
221.86MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
70.27MCNYFY2025 · Dec 31, 2025Other Non-cash Items
78.71MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
159.19MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
24.37MCNYFY2025 · Dec 31, 2025Capital Expenditures
-331.62MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.55BCNYFY2025 · Dec 31, 2025Sale of Investments
4.40BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-484.01MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
39.90MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-262.99MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-131.55MCNYFY2025 · Dec 31, 2025Other Financing Charges
9.84MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-344.81MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.12BSharesUpdated Sep 20, 2026Float Shares
612.61MSharesUpdated Sep 20, 2026% Held by Insiders
47.77%vs all stocks
% Held by Institutions
7.48%vs all stocks
Total Cash (MRQ)
2.70BCNY403.21M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.42CNYUpdated Sep 20, 2026Total Debt (MRQ)
1.92BCNY286.81M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1989xCurrent Ratio (MRQ)
3.06xBook Value per Share (MRQ)
8.63CNYUpdated Sep 20, 2026Total Assets
14.10BCNY2.10B · vs all stocks (USD)
Total Current Assets
5.99BCNYFY2025 · Dec 31, 2025Total Liabilities
4.46BCNYFY2025 · Dec 31, 2025Total Non-current Assets
8.10BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.25BCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.22BCNYFY2025 · Dec 31, 2025Cash
221.90MCNYFY2025 · Dec 31, 2025Cash Equivalents
35.40MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
257.30MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.69BCNYFY2025 · Dec 31, 2025Accounts Receivable
2.58BCNYFY2025 · Dec 31, 2025Inventory
681.09MCNYFY2025 · Dec 31, 2025Accounts Payable
708.25MCNYFY2025 · Dec 31, 2025Short-term Debt
16.66MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.58MCNYFY2025 · Dec 31, 2025Long-term Debt
1.87BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
115.42MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.12BCNYFY2025 · Dec 31, 2025Retained Earnings
2.13BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.63BCNY1.44B · vs all stocks (USD)
52-Week Low
10.70CNYUpdated Sep 20, 202652-Week High
17.76CNYUpdated Sep 20, 202652-Week Change
-28.32%vs all stocks
Beta
0.6210xvs all stocks
50-Day MA
12.51CNYUpdated Sep 20, 2026200-Day MA
13.69CNYUpdated Sep 20, 2026Avg 10-Day Volume
12.10MSharesUpdated Sep 20, 2026Avg 30-Day Volume
25.62MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.0800CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.72Profit Margin: 0.03
Financial Health
Altman Z-Score 2.59: grey zoneSignificant
Altman Z-Score: 2.59
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.03B, above the global median of $1.18BNotable
Market cap (USD): 2,025,020,263.46Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Sk Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Kodiak Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Anke Biotechnology Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nuvation Bio Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Mesoblast Limited
Tier 1ProductionApproval-Gated PipelineRule
Inspire Medical Systems, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Vazyme Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Recursion Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Urogen Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule